Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML.
Blood Adv
; 5(10): 2456-2466, 2021 05 25.
Article
in En
| MEDLINE
| ID: mdl-33999144
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2021
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
United States